GENB

Conviction 71HealthcareScan · Mon, Aug 10, 2026

GENB$14.72+2.54%

ResistanceSupportVol 14

Vol MA14 548.6K

May 11May 28Jun 16Jul 6Jul 23Aug 10

WSB mentions · 24h changelatest +100.00%· 2 mentions

May 11May 28Jun 16Jul 6Jul 23Aug 10

Generate Biomedicines, Inc.Biotechnologywww.generatebiomedicines.com ↗

Price14.72

Change+2.54%

Gap+3.69%

Rel volume2.63×

Avg volume525.04K

Avg $ vol7.3M

SMA 2013.93

SMA 5014.37

SMA 200—

Price vs 50+2.42%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 16.04

RSI (14)54

MACD hist0.11

MACD crossbull · 4d

Stoch %K / %D83 / 68

ADX (14)13

+DI / −DI24 / 22

RSI divergence—

MACD divergenceBullish

ATR %+6.22%

ADR %5.62%

52w high17.41

52w low11.21

From 52w high-15.48%

Above 52w low+31.27%

New 52w highNo

SqueezeOn · 4d

Bollinger width12.44%

%B0.95

Donchian pos83.18%

Donchian high15.17

Donchian low12.49

AVWAP (52w high)14.92

vs AVWAP high-1.38%

AVWAP (52w low)14.03

vs AVWAP low+4.89%

OBV trendDown

Chaikin MF (20)0.03

Today vs 20d2.63×

Avg vol (14d)548.6K

Avg vol (20d)525.04K

Avg $ vol (20d)7.3M

Market cap1.89B

RS 3m (vs SPY)-0.07%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank62.1

1 week+2.62%

1 month+2.72%

3 months+7.72%

6 months—

1 year—

YTD+16.32%

P/E—

P/B4.14

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current8.30

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target25.25

Target upside71.59%

Analyst ratingBuy

Institutional73.64%

Ent. value1.75B

Revenue6.31M

Net income-67.25M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out128.19M

Employees—

ListedFri, Feb 27, 2026

Free float97.95M

Float %76.4%

Short interest6.99M

Days to cover9.4d

Short volume48.0%

Squeeze score60 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.52 vs −$0.48

Last surprise-8.3% miss

Setup gradeB

Conviction71 / 100

Pattern quality—

Tech rank62.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance18.03

Support12.76

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GENB

All disclosures →

No recent disclosed trades by Congress in GENB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GENB

No recent insider (Form 4) filings in GENB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GENB · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.